Dr. Franklin M. Chu, MD

Dr. Franklin M. Chu, MD http://cdn.hgimg.com/img/prov/X/B/B/XBB36_w120h160_v3293.jpg Get a Free Background Report on Dr. Franklin M. Chu, MD. Malpractice, medical malpractice, sanctions, misconduct, credentials, and penalty or negligence information.

Specializes in Urology • Male • Age 63

15995 Tuscola Rd Suite 204
Apple Valley, CA 92307
OverviewPhone & AddressExperienceHospital QualityPatient Satisfaction

Dr. Chu's Experience

Research training, expertise and qualifications

Dr. Chu's Care Philosophy

Specialties

  • Urology

Board Certifications

  • Urology
1
  • Bladder Surgery
  • Bladder Suspension Surgery
  • Chemotherapy
  • Nephrectomy
  • Penile Prosthesis
  • Prostate Removal (incl. TURP)
2
  • Bedwetting
  • Benign Prostatic Hypertrophy (BPH)
  • Bladder Cancer
  • Bladder Disorders
  • Bladder Distention
  • Cancer
  • Erectile Dysfunction
  • Hematuria
  • Incontinence
  • Kidney Failure
  • Kidney Stones
  • Nocturia
  • Overactive Bladder
  • Penile Cancer
  • Penile Diseases
  • Prostate Cancer
  • Renal (Kidney) Cancer
  • Testicular Cancer
  • Testicular Torsion
  • Testosterone Deficiency
3

Background Check for Dr. Chu

0 Malpractice Claims

  • No malpractice history found for California.
  • No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

  • No board actions found for the years that Healthgrades collects data.
4

Awards & Recognitions

Awards

Media & Publications

  • Charles R Ream MD Award 2009 for excellence in Medical Journal Publication, 2009
  • Pathophysiology of Overactive Bladder, American Journal of Medicine Supplement, March 2006 Vol. 119 (3A) 3-8, March 2006
  • Management of Overactive Bladder and Urge Urinary Incontinence in the Elderly Patient., March 2006
  • A Clinical Study of LA2250 22.5 MG: A New Subcutaneous Depot Delivery System for Luprolide Acetate in the Treatment of Prostate Cancer., Sept. 2002
  • A Clinical Study of LA 2500 7.5MG: A New Subcutaneous Depot Delivery System for Luprolide Acetate in the Treatment of Prostate Cancer., Nov. 2002
  • Efficacy and safety of Solifenacin Succinate 10 mg Once Daily: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controll, Parellel-Group Trial in Patients With Overactive Bladder, 2009:70:
  • Management of Incontinence for Family Practice Physicians,, March 2006
  • A Twelve Month Clinical Study of LA-2585 45.0 MG: A New 6-Month, Subcutaneous Delivery System for Leuprolide Acetate for the Treatment of Prostate Cancer., 2006 Feb
  • A Phase I, multicenter, open-label study of the safety of two doses levels of a human monoclonol antibody to human alphav integrins, intetumumab, in combination with docetaxel and prednisone in patients with castration resistent metastatic prostate cancer, 2011 29:67
  • Toremifene Improves Lipid Profiles in Men Receiving Androgen Deprivation therapy for Prostate Cancer, Iterim analysis of a Multi-Center Phase III Study, April 2008
  • An Eight Month Study of LA-2573 30.0g, A new 4 month subcutaneous delivery system for Luprilide Acetate in the treatment of Porsotae., 2003 Aug
  • Extended-Release Formulations of Oxybutynin and Tolterodine Exhibit Similar Central Nervous System Tolerability Profiles: A Subanalysis of Data From the OPERA Trial., 2005 Jun
  • A new Prostate Cancer Drug: Eligard, 2000
5

Education & Training

Medical School

Tulane University School Of Medicine
Graduated in 1979

Internship Hospital

University Tex Med Br
Complete in 1980

Residency Hospital

Uc Irvine Med Center
Complete in 1985

Undergraduate Schools

Tulane University
Graduated in 1973

Other Education

University Of Illinois Urbana Champaign
Complete in 1974
6

Languages Spoken by Dr. Chu & Staff

  • English
  • Chinese, Cantonese
  • Chinese, Mandarin
Healthgrades

10 Steps to Pick the Right Doctor

Whether you need a primary care doctor or a specialist, these 10 steps will ensure you find the right doctor for you. View Slideshow

The VideoCalloutContainer had no content.